INFU:NYSEMKT, InfuSystem Holdings, Inc.

INFU stock overview

InfuSystem Holdings, Inc. (INFU:NYSEMKT) closed at $13.94 on October 23, 2026, down 1.41% on the day. The stock trades 3.3% below its 52-week high of $14.41 and 91.2% above its 52-week low of $7.29. Over the past year, it gained 37.6%. InfuSystem Holdings, Inc. is part of the Health Care sector (Medical/Dental Instruments).

Key figures

Price
$13.94
Day change
-1.41%
Volume
163,857
Average volume
138,665
Market cap
277M+
52-week range
$7.29 – $14.41
50-day average
$12.75
200-day average
$10.17

Price action over the past year

In 252 trading sessions since October 23, 2025, INFU closed higher on 131 days (52%). Its best day was August 4, 2026 (+33.62%) and its worst was May 7, 2026 (-11.54%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

INFU news

About InfuSystem Holdings, Inc.

InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, hospital outpatient, and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. It delivers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.

Similar stocks

Find more stocks like INFU with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.